Research / NVT / Fundamental state Inspectable configuration
State dimensions Filing 0001628280-25-047847 General Corporate
Debt relative to revenue 50th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.debt_to_revenue
151.17% · OPTIONAL · VALID
Capex intensity 45th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
1.76% · OPTIONAL · VALID
Operating cash generation 85th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
20.83% · OPTIONAL · VALID
Share-count growth 5th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.shares_outstanding
-2.10% · CORE · VALID
Revenue growth 100th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
34.78% · CORE · VALID
Inventory pressure 30th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
43.19% · OPTIONAL · VALID
Gross margin 10th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.gross_margin
37.45% · CORE · VALID
Operating margin 45th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
15.78% · CORE · VALID
R&D intensity 5th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
1.95% · OPTIONAL · VALID
SBC intensity 85th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
1.02% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 34 states Self-history eligible
Sep 30, 2021 10/10 normalized Level 3 Dec 31, 2021 10/10 normalized Level 3 Mar 31, 2022 10/10 normalized Level 3 Jun 30, 2022 7/7 normalized Level 3 Sep 30, 2022 7/7 normalized Level 3 Dec 31, 2022 10/10 normalized Level 3 Mar 31, 2023 10/10 normalized Level 3 Jun 30, 2023 10/10 normalized Level 3 Sep 30, 2023 10/10 normalized Level 3 Dec 31, 2023 10/10 normalized Level 3 Mar 31, 2024 10/10 normalized Level 3 Jun 30, 2024 10/10 normalized Level 3 Sep 30, 2024 10/10 normalized Level 3 Dec 31, 2024 10/10 normalized Level 3 Mar 31, 2025 10/10 normalized Level 3 Jun 30, 2025 10/10 normalized Level 3 Sep 30, 2025 10/10 normalized Level 3 Dec 31, 2025 10/10 normalized Level 3 Mar 31, 2026 10/10 normalized Level 3 Jun 30, 2026 10/10 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 183.36%
Current 151.17%
Delta -32.19% Capex Intensity Increased
Previous 1.75%
Current 1.76%
Delta 0.01% Cash Generation Increased
Previous -1.75%
Current 20.83%
Delta 22.58% Dilution Increased
Previous -3.17%
Current -2.10%
Delta 1.07% Growth Increased
Previous 9.41%
Current 34.78%
Delta 25.38% Inventory Pressure Increased
Previous 43.15%
Current 43.19%
Delta 0.04% Margin Decreased
Previous 38.60%
Current 37.45%
Delta -1.16% Profitability Decreased
Previous 16.27%
Current 15.78%
Delta -0.49% R And D Intensity Decreased
Previous 1.98%
Current 1.95%
Delta -0.03% Sbc Intensity Decreased
Previous 1.20%
Current 1.02%
Delta -0.19% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.